Bioconjugated fluorescent polymeric nanoparticles for imaging and targeted therapy of HER2-overexpressing cancer cells

Journal of Fluorescence

Volumn 21, Issue 4, 2011, Pages 1669-1676

  Way, Tzong Der ^a   Chang, Chi Jung ^b   Lin, Cheng Wen ^b  

^a FENG CHIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cancer cell; Fluorescent polymers; Imaging; Nanoparticles; Targeted therapy

Indexed keywords

CANCER CELLS; CELL CYCLE; CORE/SHELL; FLUORESCENT CONJUGATED POLYMERS; FLUORESCENT POLYMERS; HERCEPTIN; POLYMERIC NANOPARTICLES; TARGETED THERAPY; THERAPEUTIC EFFECTS; TUMOR TARGETING;

BIOSYNTHESIS; CELL DEATH; CONJUGATED POLYMERS; DISEASES; FLUORESCENCE; IMAGING TECHNIQUES; NANOPARTICLES; TUMORS;

FUNCTIONAL POLYMERS;

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; NANOPARTICLE; POLYMER; TRASTUZUMAB;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL STRAIN 3T3; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; FLUORESCENCE; HUMAN; MOLECULAR IMAGING; MOUSE; SYNTHESIS; TISSUE DISTRIBUTION; TUMOR CELL CULTURE;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCENCE; HUMANS; MICE; MOLECULAR IMAGING; MOLECULAR STRUCTURE; NANOPARTICLES; NIH 3T3 CELLS; POLYMERS; RECEPTOR, ERBB-2; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 80053383633     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-011-0856-9     Document Type: Article

References (26)

1. Nicolette CA, Miller GA (2003) The identification of clinically relevant markers and therapeutic targets. Drug Discov Today 8 (1):31-38 (Pubitemid 36143626)
2. Sun C, Sze R, Zhang M (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 78A(3):550-557 (Pubitemid 44253539)
3. Toublan FJJ, Boppart S, Suslick KS (2006) Tumor targeting by surface-modified protein microspheres. J Am Chem Soc 128 (11):3472-3473
4. Yu X, Chen L, Deng Y, Li K, Wang Q, Li Y, Xiao S, Zhou L, Luo X, Liu J, Pang D (2007) Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation. J Fluoresc 17(2):243-247 (Pubitemid 46355032)
5. Xue FL, Chen JY, Guo J, Wang CC, Yang WL, Wang PN, Lu DR (2007) Enhancement of intracellular delivery of CdTe quantum dots (QDs) to living cells by tat conjugation. J Fluoresc 17(2):149-154 (Pubitemid 46355022)
6. Yang CS, Chang CH, Tsai PJ, Chen WY, Tseng FG, Lo LW (2004) Nanoparticle- based in vivo investigation on blood-brain barrier permeability following ischemia and reperfusion. Anal Chem 76(15):4465-4471
7. Zhao Y, Liu S, Li Y, Jiang W, Chang Y, Pan S, Fang X, Wang YA, Wang J (2010) Synthesis and grafting of folate-PEG-PAMAM conjugates onto quantum dots for selective targeting of folatereceptor- positive tumor cells. J Colloid Interf Sci 350(1):44-50
8. Das GK, Chan PPY, Teo A, Loo JSC, Anderson JM, Tan TTY (2010) In vitro cytotoxicity evaluation of biomedical nanoparticles and their extracts. J Biomed Mater Res A 93A(1):337-346
9. Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R (2006) Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2(12):1412-1417 (Pubitemid 44786881)
10. Hsieh SR, Chang CJ, Way TD, Kwan PC, Hung TW (2009) Preparation and non-invasive in-vivo imaging of anti-adhesion barriers with fluorescent polymericmarks. J Fluoresc 19(4):733-740
11. Way TD, Hsieh SR, Chang CJ, Hung TW, Chiu CW (2010) Preparation and characterization of branched polymers as postoperative anti-adhesion barriers. Appl Surf Sci 256(10):3330-3336
12. Pei Q, Yang Y (1996) Efficient photoluminescence and electroluminescence from a soluble polyfluorene. J Am Chem Soc 118 (31):7416-7417 (Pubitemid 26270637)
13. Feng X, Tang Y, Duan X, Liu L, Wang S (2010) Lipid-modified conjugated polymer nanoparticles for cell imaging and transfection. J Mater Chem 20:1312-1316
14. Stearns V, Schneider B, Henry NL, Hayes DF, Flockhart DA (2006) Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 6:886-893 (Pubitemid 44629900)
15. Slamon D, Godolphin W, Jones L, Holt J, Wong S, Keith D, Levin W, Stuart S, Udove J, Ullrich A (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (4905):707-712 (Pubitemid 19147683)
16. Slamon D, Clark G, Wong SG, Levin W, Ullrich A, McGuire W (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (4785):177-182 (Pubitemid 17231334)
17. Yu D, Hung MC (2000) Role of erbB2 in breast cancer chemosensitivity. Oncogene 22(7):673-680
18. Lee JC, Tsai CY, Kao JY, Kao MC, Tsai SC, Chang CS, Huang LJ, Kuo SC, Lin JK, Way TD (2008) Geraniin-mediated apoptosis by cleavage of focal adhesion kinase through up-regulation of Fas ligand expression in human melanoma cells. Mol Nutr Food Res 52(6):655-663
19. Schwartz BJ (2003) Conjugated polymers as molecular materials: how chain conformation and film morphology influence energy transfer and interchain interactions. Annu Rev Phys Chem 54:141-172
20. Chandler D (2005) Interfaces and the driving force of hydrophobic assembly. Nature 437:640-647 (Pubitemid 41486526)
21. Wong KF, Skaf MS, Yang CY, Rossky PJ, Bagchi B, Hu D, Yu J, Barbara PF (2001) Structural and electronic characterization of chemical and conformational defects in conjugated polymers. J Phys Chem B 105(26):6103-6107 (Pubitemid 35344231)
22. Martini IB, Smith AD, Schwartz BJ (2004) Exciton-exciton annihilation and the production of interchain species in conjugated polymer films: Comparing the ultrafast stimulated emission and photoluminescence dynamics of MEH-PPV. Phys Rev B: Condens Matter B69:035204
23. Hun X, Zhang Z, Tiao L (2008) Anti-Her-2 monoclonal antibody conjugated polymer fluorescent nanoparticles probe for ovarian cancer imaging. Anal Chim Acta 625(2):201-206
24. Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D (1997) Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 36(1):66-75 (Pubitemid 27024679)
25. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25:4798-4811 (Pubitemid 44187627)
26. Peralta-Leal A, Rodríguez MI, Oliver FJ (2008) Poly(ADP-ribose) polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment. Clin Transl Oncol 10(6):318-323